As of 2026-10-04, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 9.53 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.23 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -91.8%.
The range of the Relative Valuation is 6.97 - 12.35 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 15.5x | 14.8x |
| Forward P/E multiples | 15.5x - 20.3x | 18.9x |
| Fair Price | 6.97 - 12.35 | 9.53 |
| Upside | -94.0% - -89.4% | -91.8% |
| Date | P/E |
| 2026-10-02 | 227.69 |
| 2026-10-01 | 223.37 |
| 2026-09-30 | 225.73 |
| 2026-09-29 | 224.77 |
| 2026-09-28 | 226.52 |
| 2026-09-25 | 227.44 |
| 2026-09-24 | 232.16 |
| 2026-09-23 | 221.25 |
| 2026-09-22 | 230.19 |
| 2026-09-21 | 222.85 |
| 2026-09-18 | 216.06 |
| 2026-09-17 | 225.01 |
| 2026-09-16 | 219.03 |
| 2026-09-15 | 217.09 |
| 2026-09-14 | 219.01 |
| 2026-09-11 | 220.95 |
| 2026-09-10 | 225.13 |
| 2026-09-09 | 226.65 |
| 2026-09-08 | 223.28 |
| 2026-09-04 | 218.66 |
| 2026-09-03 | 220.97 |
| 2026-09-02 | 216.33 |
| 2026-09-01 | 222.11 |
| 2026-08-31 | 222.05 |
| 2026-08-28 | 223.09 |
| 2026-08-27 | 229.06 |
| 2026-08-26 | 234.68 |
| 2026-08-25 | 242.07 |
| 2026-08-24 | 241.42 |
| 2026-08-21 | 239.48 |
| 2026-08-20 | 237.13 |
| 2026-08-19 | 233.16 |
| 2026-08-18 | 231.35 |
| 2026-08-17 | 229.53 |
| 2026-08-14 | 224.24 |
| 2026-08-13 | 216.49 |
| 2026-08-12 | 219.76 |
| 2026-08-11 | 219.13 |
| 2026-08-10 | 223.77 |
| 2026-08-07 | 217.00 |
| 2026-08-06 | 211.47 |
| 2026-08-05 | 216.84 |
| 2026-08-04 | 215.10 |
| 2026-08-03 | 220.97 |
| 2026-07-31 | 224.28 |
| 2026-07-30 | 231.79 |
| 2026-07-29 | 182.09 |
| 2026-07-28 | 184.52 |
| 2026-07-27 | 178.50 |
| 2026-07-24 | 186.81 |